Application: Used as Ensitrelvir (S-217622) Intermediates. We can provide CDMO services for COVID-19 drugs with sufficient capacity. Contact us at email@example.com now.
Ensitrelvir (code name S-217622) is an oral antiviral drug, which acts as an orally active 3C-like protease inhibitor for the treatment of COVID-19 infection. It has demonstrated antiviral effectiveness against Delta variant and the recently emerged Omicron variant.